Author response to: Impact of postoperative chemotherapy on survival for oesophagogastric adenocarcinoma after preoperative chemotherapy and surgery

por Rahman, Saqib A, Underwood, Timothy J
Publicado 2022

The Oesophageal Cancer Multidisciplinary Team: Can Machine Learning Assist Decision-Making?

por Thavanesan, Navamayooran, Vigneswaran, Ganesh, Bodala, Indu, Underwood, Timothy J.
Publicado 2023

Perforated diverticulitis presenting as necrotising fasciitis of the leg

por Underwood, Timothy J, Southgate, Jeremy, Talbot, Robert, Nash, Guy F
Publicado 2008

Histone Modifying Enzymes as Targets for Therapeutic Intervention in Oesophageal Adenocarcinoma

por Pickering, Oliver J., Breininger, Stella P., Underwood, Timothy J., Walters, Zoë S.
Publicado 2021

The genetic profile and molecular subtypes of human pseudomyxoma peritonei and appendiceal mucinous neoplasms: a systematic review

por Murage, Nora Wangari, Ahmed, Nada Mabrouk, Underwood, Timothy J., Walters, Zoë S., Breininger, Stella Panagio
Publicado 2023

The relevance of the Siewert classification in the era of multimodal therapy for adenocarcinoma of the gastro-oesophageal junction

por Curtis, Nathan J, Noble, Fergus, Bailey, Ian S, Kelly, Jamie J, Byrne, James P, Underwood, Timothy J
Publicado 2014

Fibroblasts derived from oesophageal adenocarcinoma differ in DNA methylation profile from normal oesophageal fibroblasts

por Smith, Eric, Palethorpe, Helen M., Hayden, Annette L., Young, Joanne P., Underwood, Timothy J., Drew, Paul A.
Publicado 2017

The AUGIS Survival Predictor: Prediction of Long-Term and Conditional Survival After Esophagectomy Using Random Survival Forests

por Rahman, Saqib A., Walker, Robert C., Maynard, Nick, Nigel Trudgill, Crosby, Tom, Cromwell, David A., Underwood, Timothy J.
Publicado 2023

The Development, Application and Analysis of an Enhanced Recovery Programme for Major Oesophagogastric Resection

por Underwood, Timothy J., Noble, F., Madhusudan, N., Sharland, D., Fraser, R., Owsley, J., Grant, M., Kelly, J. J., Byrne, James P.
Publicado 2017

Quantitative proteomic profiling of primary cancer-associated fibroblasts in oesophageal adenocarcinoma

por Manousopoulou, Antigoni, Hayden, Annette, Mellone, Massimiliano, Garay-Baquero, Diana J., White, Cory H., Noble, Fergus, Lopez, Monette, Thomas, Gareth J., Underwood, Timothy J., Garbis, Spiros D.
Publicado 2018

Cancer-associated fibroblasts predict poor outcome and promote periostin-dependent invasion in oesophageal adenocarcinoma

por Underwood, Timothy J, Hayden, Annette L, Derouet, Mathieu, Garcia, Edwin, Noble, Fergus, White, Michael J, Thirdborough, Steve, Mead, Abbie, Clemons, Nicholas, Mellone, Massimiliano, Uzoho, Chudy, Primrose, John N, Blaydes, Jeremy P, Thomas, Gareth J
Publicado 2015

Pharmacological EZH2 inhibition combined with retinoic acid treatment promotes differentiation and apoptosis in rhabdomyosarcoma cells

por O’Brien, Eleanor, Tse, Carmen, Tracy, Ian, Reddin, Ian, Selfe, Joanna, Gibson, Jane, Tapper, William, Pengelly, Reuben J., Gao, Jinhui, Aladowicz, Ewa, Petts, Gemma, Thway, Khin, Popov, Sergey, Kelsey, Anna, Underwood, Timothy J., Shipley, Janet, Walters, Zoë S.
Publicado 2023

Exosomal microRNAs derived from colorectal cancer-associated fibroblasts: role in driving cancer progression

por Bhome, Rahul, Goh, Rebecca W., Bullock, Marc D., Pillar, Nir, Thirdborough, Stephen M., Mellone, Massimiliano, Mirnezami, Reza, Galea, Dieter, Veselkov, Kirill, Gu, Quan, Underwood, Timothy J., Primrose, John N., De Wever, Olivier, Shomron, Noam, Sayan, A. Emre, Mirnezami, Alex H.
Publicado 2017

Tumour infiltrating lymphocytes correlate with improved survival in patients with oesophageal adenocarcinoma

por Noble, Fergus, Mellows, Toby, McCormick Matthews, Leo H., Bateman, Adrian C., Harris, Scott, Underwood, Timothy J., Byrne, James P., Bailey, Ian S., Sharland, Donna M., Kelly, Jamie J., Primrose, John N., Sahota, Surinder S., Bateman, Andrew R., Thomas, Gareth J., Ottensmeier, Christian H.
Publicado 2016

Targeting the Myofibroblastic Cancer-Associated Fibroblast Phenotype Through Inhibition of NOX4

por Hanley, Christopher J, Mellone, Massimiliano, Ford, Kirsty, Thirdborough, Steve M, Mellows, Toby, Frampton, Steven J, Smith, David M, Harden, Elena, Szyndralewiez, Cedric, Bullock, Marc, Noble, Fergus, Moutasim, Karwan A, King, Emma V, Vijayanand, Pandurangan, Mirnezami, Alex H, Underwood, Timothy J, Ottensmeier, Christian H, Thomas, Gareth J
Publicado 2017

Authentication and characterisation of a new oesophageal adenocarcinoma cell line: MFD-1

por Garcia, Edwin, Hayden, Annette, Birts, Charles, Britton, Edward, Cowie, Andrew, Pickard, Karen, Mellone, Massimiliano, Choh, Clarisa, Derouet, Mathieu, Duriez, Patrick, Noble, Fergus, White, Michael J., Primrose, John N., Strefford, Jonathan C., Rose-Zerilli, Matthew, Thomas, Gareth J., Ang, Yeng, Sharrocks, Andrew D., Fitzgerald, Rebecca C., Underwood, Timothy J.
Publicado 2016

Author Correction: Authentication and characterisation of a new oesophageal adenocarcinoma cell line: MFD-1

por Garcia, Edwin, Hayden, Annette, Birts, Charles, Britton, Edward, Rogerson, Connor, Bleaney, Christopher W., Cowie, Andrew, Pickard, Karen, Mellone, Massimiliano, Choh, Clarisa, Derouet, Mathieu, Duriez, Patrick, Noble, Fergus, White, Michael J., Primrose, John N., Strefford, Jonathan C., Rose-Zerilli, Matthew, Thomas, Gareth J., Ang, Yeng, Sharrocks, Andrew D., Fitzgerald, Rebecca C., Underwood, Timothy J.
Publicado 2019

Induction of fibroblast senescence generates a non-fibrogenic myofibroblast phenotype that differentially impacts on cancer prognosis

por Mellone, Massimiliano, Hanley, Christopher J., Thirdborough, Steve, Mellows, Toby, Garcia, Edwin, Woo, Jeongmin, Tod, Joanne, Frampton, Steve, Jenei, Veronika, Moutasim, Karwan A., Kabir, Tasnuva D., Brennan, Peter A, Venturi, Giulia, Ford, Kirsty, Herranz, Nicolas, Lim, Kue Peng, Clarke, James, Lambert, Daniel W., Prime, Stephen S., Underwood, Timothy J., Vijayanand, Pandurangan, Eliceiri, Kevin W., Woelk, Christopher, King, Emma V., Gil, Jesus, Ottensmeier, Christian H., Thomas, Gareth J.
Publicado 2016

Phosphodiesterase type 5 inhibitors enhance chemotherapy in preclinical models of esophageal adenocarcinoma by targeting cancer-associated fibroblasts

por Sharpe, Benjamin P., Hayden, Annette, Manousopoulou, Antigoni, Cowie, Andrew, Walker, Robert C., Harrington, Jack, Izadi, Fereshteh, Breininger, Stella P., Gibson, Jane, Pickering, Oliver, Jaynes, Eleanor, Kyle, Ewan, Saunders, John H., Parsons, Simon L., Ritchie, Alison A., Clarke, Philip A., Collier, Pamela, Mongan, Nigel P., Bates, David O., Yacqub-Usman, Kiren, Garbis, Spiros D., Walters, Zoë, Rose-Zerilli, Matthew, Grabowska, Anna M., Underwood, Timothy J.
Publicado 2022

Ordering of mutations in preinvasive disease stages of esophageal carcinogenesis

por Weaver, Jamie M.J., Ross-Innes, Caryn S., Shannon, Nicholas, Lynch, Andy G., Forshew, Tim, Barbera, Mariagnese, Murtaza, Muhammed, Ong, Chin-Ann J., Lao-Sirieix, Pierre, Dunning, Mark J, Smith, Laura, Smith, Mike L., Anderson, Charlotte L., Carvalho, Benilton, O’Donovan, Maria, Underwood, Timothy J., May, Andrew P, Grehan, Nicola, Hardwick, Richard, Davies, Jim, Oloumi, Arusha, Aparicio, Sam, Caldas, Carlos, Eldridge, Matthew D., Edwards, Paul A.W., Rosenfeld, Nitzan, Tavaré, Simon, Fitzgerald, Rebecca C
Publicado 2014